US 10612027
Modified double-stranded RNA agents
granted A61PA61P43/00
Quick answer
US patent 10612027 (Modified double-stranded RNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P43/00